A new technology for cellular immunotherapy developed by Abramson Cancer Center researchers at Penn Medicine showed promising anti-tumor activity in […]
(HealthDay)—An enhanced recovery after surgery (ERAS) program for cesarean delivery is associated with improved outcomes, according to a study published […]
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok